March 25, 2020 / 11:44 AM / 3 days ago

BRIEF-Silence Therapeutics Says Collaborating With Astrazeneca On siRNA Therapeutics

March 25 (Reuters) - AstraZeneca PLC:

* SILENCE THERAPEUTICS- COLLABORATION WITH ASTRAZENECA TO DISCOVER & DEVELOP SIRNA THERAPEUTICS FOR CARDIOVASCULAR, RENAL, METABOLIC & RESPIRATORY DISEASES

* SILENCE THERAPEUTICS- ASTRAZENECA TO INVEST $80 MILLION THROUGH UPFRONT CASH AND EQUITY INVESTMENT IN SILENCE

* SILENCE THERAPEUTICS- FOR EACH DISEASE TARGET, SILENCE IS ELIGIBLE TO RECEIVE UP TO $400 MILLION IN MILESTONES, PLUS TIERED ROYALTIES

* SILENCE THERAPEUTICS- RETAINS OPTION TO CO-DEVELOP TWO PROGRAMS DISCOVERED THROUGH COLLABORATION

* SILENCE THERAPEUTICS PLC - COMPANIES ANTICIPATE INITIATING WORK ON FIVE TARGETS WITHIN FIRST THREE YEARS OF COLLABORATION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below